Condition
Coma; Prolonged
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed1
Not Yet Recruiting1
Enrolling By Invitation1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07074678Not ApplicableEnrolling By Invitation
Prognostication of Recovery in Early Disorders of Consciousness Study
NCT07736820Not Yet Recruiting
Multimodal Assessment and Prognosis in Disorders of Consciousness After Severe Brain Injury (CyDoC-MAP)
NCT04921683Not ApplicableCompleted
The Use of LIFUP in Chronic Disorders of Consciousness
NCT03443037UnknownPrimary
Benefits of Amantadine in Patients With Coma State
Showing all 4 trials